-
1 Comment
Regent Pacific Group Limited is currently in a long term uptrend where the price is trading 1.9% above its 200 day moving average.
From a valuation standpoint, the stock is 69.8% more expensive than other stocks from the Financial Services sector with a price to sales ratio of 75.4.
Finally, its free cash flow fell by 0.0% to $-2M since the same quarter in the previous year.
Based on the above factors, Regent Pacific Group Limited gets an overall score of 1/5.
| Exchange | F |
|---|---|
| CurrencyCode | EUR |
| Sector | Financial Services |
| Industry | Asset Management |
| ISIN | None |
| Market Cap | 45M |
|---|---|
| PE Ratio | None |
| Beta | 0.42 |
| Target Price | None |
| Dividend Yield | None |
Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences companies in China, Europe, Hong Kong, and Taiwan. It operates in two segments, Biopharma and Corporate Investment. The company engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence (?AI?) systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management and corporate finance services. Regent Pacific Group Limited was incorporated in 1991 and is headquartered in Central, Hong Kong.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for RPGA.F using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
